fbpx
QQQ
-0.22
284.63
-0.08%
DIA
-1.04
284.05
-0.37%
SPY
-0.65
343.95
-0.19%
TLT
-0.55
159.80
-0.35%
GLD
+ 1.40
177.86
+ 0.78%

Aurora Cannabis Stock Plunges 18% After Q4 Earnings Call

September 22, 2020 7:05 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print More

Aurora Cannabis Inc. (NYSE:ACB) shares plunged over 18% after hours following the release of the company’s fourth-quarter earnings results.

The Edmonton, Canada-based company reported losing more than CA$3.3 billion ($2.5 billion) in the fiscal year closing Tuesday.

On Monday, Jefferies upgraded Aurora from Underperform to Hold. This, along with anticipation for Tuesday's earnings call, caused the cannabis giant’s stock to rise, closing Tuesday up 15%. However, excitement fell after the company released its quarterly earnings, causing the stock price to plunge to over 18% after the market close.

“Aurora has slipped from its top position in Canadian consumer, a market that continues to support material growth and opportunity," admitted recently-appointed CEO Miguel Martin.

Martin was appointed earlier this month in replacement of interim CEO and Executive Chairman Michael Singer, and is the third CEO the company had in 2020, after the retirement of Terry Booth in February.

"My focus is therefore to re-position the Canadian consumer business immediately. We look to expand beyond the value flower segment, leverage our capabilities in science and product innovation and put our effort on a finite number of emerging growth formats,” said Martin.

Aurora’s total net revenue of CA$72.1 million ($54.1 million) signified a 5% drop from the previous quarter.

Net revenue for consumer cannabis in the recreational market was CA$35.3 million ($26.7 million) dropping 9% from the previous quarter. Medical cannabis net revenue was $32.2 million ($24.2 million), a 4% increase from the prior quarter, attributed to an overall market growth in Canada and Europe.

Net loss from continuing operations was CA$1.86 billion ($1.40 billion).

The company offered guidance for the first quarter of the following fiscal year. Net revenue is expected to be between CA$60 million and CA$64 million, compared to CA$67.5 million in the fourth quarter of 2020, and will be composed exclusively from cannabis net revenue.

The company expects to achieve positive Adjusted EBITDA in the second quarter of 2021.

Lead image by Ilona Szentivanyi. Copyright: Benzinga.


Related Articles

Magic Johnson-Backed Uncle Bud's To Enter Asia Market In November

Uncle Bud's, a hemp and CBD brand backed by Earvin "Magic" Johnson, is poised to debut in Asia. The NBA Lakers legend and Basketball Hall of Famer will launch the brand's newest shop on Nov. 6 on Tmall Global, China's business-to-consumer (B2C) cross-border online platform. read more

Jushi Raises CA$35.5M Equity Offering

Cannabis and hemp company Jushi Holdings Inc. (CSE: JUSH) (OTCQB: JUSHF) is poised to raise CA$35.5 million through an overnight marketed offering. read more

Puration Buys Dallas Area Farmland For $1.3M

Puration Inc. read more

Ontario Boosts Canadian Cannabis Sales To Reach $245M In August

Canada cannabis sales increased 94% over the year and 6% sequentially to CA$244.9 million in August. According to Statistics Canada, the growth can be attributed to the expansion of the retail footprint across provinces, including British Columbia and especially Ontario. read more

Flowr Poised To Acquire Terrace Global Via CA$63M Deal

The Flowr Corp. (TSX.V: FLWR) (OTCPK: FLWPF), a global cannabis company, is acquiring Terrace Global Inc. (TSXV: TRCE). read more